Navigation Links
Governor Bredesen Declares Tennessee Patient Advocacy Day to Promote Healthcare Accessibility for All
Date:6/17/2008

Bredesen Joins National Patient Advocate Foundation in Supporting Progressive, Financially Sound and Effective Healthcare Solutions

Tennesseans to Show Their Support by Wearing Blue and Yellow Ribbons on June 19

NASHVILLE, Tenn., June 17 /PRNewswire-USNewswire/ -- Emphasizing the need for all patients in Tennessee to have ready access to the best possible healthcare when illness strikes, Governor Phil Bredesen, for the second consecutive year, has declared June 19 Patient Advocacy Day. Patients, caregivers and other members of Tennessee's health care community have been asked to demonstrate their support by wearing a blue or gold ribbon and will participate in this initiative to raise awareness for needed access to timely, consistent and quality healthcare for all patients, including those facing financial hardships and obstacles hindering their access to care.

This national effort is sponsored by National Patient Advocate Foundation (NPAF), a Washington, DC based organization that works to bring a patient voice to the forefront of health policy discussions, and to help patients from all backgrounds receive the appropriate care when diagnosed with an illness. NPAF and its nationwide network of volunteers address such issues as access to clinical trials and cancer screenings; patient concerns related to Health Information Technology; and expansion of State Medicaid programs to cover those that are uninsured when diagnosed with cancer.

"We appreciate Governor Bredesen for his support and for recognizing that access to healthcare is a basic human need and a shared societal responsibility," said Wendy G. Santee, Tennessee State Policy Liaison for NPAF. "His ongoing commitment to the health of all Tennesseans serves as an example for other states."

In addition to Governor Bredesen, NPAF's efforts are being supported by Secretary of State Riley Darnell, Commissioner Susan R. Cooper, MSN, RN of the Tennessee Department of Health, a
'/>"/>

SOURCE National Patient Advocate Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Governor Rendell Offers adultBasic Coverage to 35,000 Uninsured Pennsylvanians
2. New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 8
3. Governor Rendell Announces $2.1 Million Investment in Small Transit Vehicles
4. Governor Rendell Proclaims Sept. 9-15 as Senior Community Center Week
5. Michigan Hospitals Receive Governors Award
6. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
7. Los Angeles Area Chamber of Commerce Endorses Governor Schwarzeneggers Health Care Proposal
8. Governor Rendell Announces CHIP Enrollment Clinics at Several Rite Aid Stores
9. $8,000 Winning Bids at Governors Livestock Auction to Benefit College-Bound Youth and Homeless
10. Blue Cross of California and the California Governors Council on Physical Fitness and Sports Launch Live Like a Champion Tour
11. AARP Calls on Governor Schwarzenegger to Discourage Veto of SCHIP Expansion Bill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... York (PRWEB) June 19, 2013 Parker ... the rights of victims injured by dangerous drugs and ... an Arizona woman who alleges that she was ... filed on May 30th in the U.S. District Court ... No. 2:13-cv-12677) in the multidistrict litigation entitled In Re: ...
(Date:6/18/2013)... Colorado (PRWEB) June 18, 2013 Daily Gossip ... latest product reviews and useful articles. , The magazine ... introducing them to a new anabolic recipe every week ... Book is the perfect guide for readers who are ... , Reporters at Daily Gossip reveals that anabolic food is ...
(Date:6/18/2013)... 18, 2013 The Temp1000IS temperature ... stand-alone device which can be used to automatically record ... enclosure of the Temp1000IS comes with the serial number ... IFC400 (sold separately) docking station and can ... communications. No more removal of end-caps to download data. ...
(Date:6/18/2013)... Palo Alto has taken yet another step in ... its recent major long-term solar power commitment. , Last ... power purchase agreements , which together will result in the ... electric power per year, which is the equivalent of roughly ... power to supply all 65,000+ Palo Alto residents---and then some! ...
(Date:6/18/2013)... 18, 2013 Internationally acclaimed plastic ... website, thebestbreast.com, showcasing his unique approach to breast ... about his surgical method and highlights the results ... his website, Dr. Tebbetts compares his breast augmentation ... Dr. Tebbetts’ method does not necessitate the use ...
Breaking Medicine News(10 mins):Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 2Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 3Health News:Boston Scientific and American Medical Systems Named in Transvaginal Mesh Lawsuit Filed by Parker Waichman LLP on Behalf of Arizona Woman 4Health News:Anabolic Cooking Book Review Exposes Dave Ruel’s Top 10 ‘Anabolicious’ Recipes for BodyBuilders 2Health News:MadgeTech, Inc. Introduces the New Temp1000IS Intrinsically Safe High Temperature Data Logger 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3Health News:Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website 2
... visually impaired, navigating city streets or neighborhoods has constant challenges. ... rudimentary technologya simple caneto help them make their way through ... California engineering researchers is working to change that by developing ... design first shown a year ago is now being further ...
... Steven Reinberg HealthDay Reporter , WEDNESDAY, May ... prescribed drugs, the antidepressant Paxil and the cholesterol-lowering medication ... new study finds. The increase is most apparent ... is already too high, the researchers noted. "This ...
... 2011) The Maryland Stem Cell Research Commission (Commission) ... in response to its three FY 2011 Requests for ... Technology Development Corporation (TEDCO) approved the Commission,s recommendation to ... Research Fund,s (MSCRF) $10.4 million FY 2011 budget. ...
... May 25 (HealthDay News) -- The Internet has put the ... also allowed banned or controlled substances to slip within their ... online May 19 in Drug Testing and Analysis , ... contain ingredients other than those claimed and can be hazardous. ...
... obese women with less-than-optimal levels of vitamin D who lose ... increases in circulating levels of this fat-soluble nutrient, according to ... Center. , "Since vitamin D is generally lower in persons ... account, in part, for the link between obesity and diseases ...
... known for years that playing violent video games causes ... a new University of Missouri (MU) study provide one ... video game players become less responsive to violence, and ... "Many researchers have believed that becoming desensitized to ...
Cached Medicine News:Health News:'Guide vests' -- robotic navigation aids for the visually impaired 2Health News:Combo of Paxil, Pravachol May Raise Blood Sugar 2Health News:Combo of Paxil, Pravachol May Raise Blood Sugar 3Health News:Maryland Stem Cell Research Commission funds 36 new projects in FY 2011 2Health News:Maryland Stem Cell Research Commission funds 36 new projects in FY 2011 3Health News:Illegal Drugs Easy to Buy on the Internet, U.K. Study Finds 2Health News:Losing more than 15 percent of body weight significantly boosts vitamin D levels in overweight women 2Health News:Losing more than 15 percent of body weight significantly boosts vitamin D levels in overweight women 3Health News:Violent video games reduce brain response to violence and increase aggressive behavior 2
(Date:6/18/2013)... 18, 2013 Decision Resources, one of the world,s ... finds that, over the past 12 months, 25 percent of ... Germany , Italy , ... Kingdom ) have been required to change the antiretroviral ... primarily to reduce costs. Additionally, more than 40 percent of ...
(Date:6/18/2013)... YORK , June 18, 2013 JDRF and ... are accelerating the development of new products that combine BD,s ... collaboration announced today. This new, three-year commitment is an extension ... Many patients with T1D not only take daily ... be placed in the body for a number of days ...
(Date:6/18/2013)... 18, 2013 Today, Wall Street Reports ... GILD ), Health Management Associates Inc. (NYSE: ... ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ), and Trius ... free of charge - including full price targets, industry analysis ... Gilead Sciences, Inc. Research Report On June 7, ...
Breaking Medicine Technology:One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6
... presented at,the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) ... continue,to offer new and better treatment options for breast ... for longer if the medicines are,given before and after ... , , Key data ...
... Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) today announced ... AZ-004 (Staccato(R) loxapine). This Phase 3,clinical trial was ... Both the 5 mg and 10 mg doses of ... a statistically significant reduction in,agitation from baseline to the ...
Cached Medicine Technology:New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer 2New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer 3New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer 4Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 2Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 3Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 4Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 5Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 6Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 7Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 8Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 9Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial 10
Inquire...
Inquire...
... Anatomical Malar I Implants - Providing ... implant follows the contour of the zygoma ... prominence. Anatomical Malar II Implants - ... the surgeon with another augumentation option that ...
... - Anatomically designed to enhance the chin contour, ... mandible with a high-profile central chin projection. ... entire mandible, this implant provides a high central ... arms. Cleft Chin Implants - Designed with ...
Medicine Products: